In silico design of anti-atherogenic biomaterials. - Wikidata - awgldk - TriplyDB

In silico design of anti-atherogenic biomaterials.

In silico design of anti-atherogenic biomaterials.

http://www.wikidata.org/entity/Q34869890

about

Impact of hydrophobic chain composition on amphiphilic macromolecule antiatherogenic bioactivity Sugar-based amphiphilic nanoparticles arrest atherosclerosis in vivo.Tartaric acid-based amphiphilic macromolecules with ether linkages exhibit enhanced repression of oxidized low density lipoprotein uptake.Carbohydrate-derived amphiphilic macromolecules: a biophysical structural characterization and analysis of binding behaviors to model membranes.Computational Analysis of Structure-Based Interactions for Novel H₁-Antihistamines.Designing polymers with sugar-based advantages for bioactive delivery applications Nanotherapeutics for inhibition of atherogenesis and modulation of inflammation in atherosclerotic plaques.Amphiphilic macromolecule nanoassemblies suppress smooth muscle cell proliferation and platelet adhesion

P2860

Q34149692-E026BFAA-EE0D-4571-83DE-DB8BA4090325 Q35157103-24D0497C-BFB7-40FF-BA6B-F4EB567CBC9A Q35516987-10D70BB6-42D3-402E-A81A-4A4FB6E6F065 Q35824486-32CC3A79-3065-433B-8746-3119406821BC Q35900766-3338538F-A4D2-4912-B96D-EF3659C755B8 Q36307576-3A67AA9B-89B7-4AFE-85ED-CF0A7F54EABD Q36496336-2E928A90-163B-48B5-A85D-A0945A344426 Q36586068-F87A7B5B-1DE3-45C1-9007-D967ACDC4916

P2860

In silico design of anti-atherogenic biomaterials.

http://www.wikidata.org/entity/Q34869890

description

2013 nî lūn-bûn

@nan

2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

In silico design of anti-atherogenic biomaterials.

@ast

In silico design of anti-atherogenic biomaterials.

@en

In silico design of anti-atherogenic biomaterials.

@nl

type

label

In silico design of anti-atherogenic biomaterials.

@ast

In silico design of anti-atherogenic biomaterials.

@en

In silico design of anti-atherogenic biomaterials.

@nl

prefLabel

In silico design of anti-atherogenic biomaterials.

@ast

In silico design of anti-atherogenic biomaterials.

@en

In silico design of anti-atherogenic biomaterials.

@nl

P1433

Q34869890-1D11F02E-F0DD-4DF2-B657-21ABB7220880

P1476

Q34869890-FCB1B595-A271-43A6-B7F1-DF808067F735

P2093

Q34869890-17F9BA79-CD45-48D2-B8BC-067FE4490635

Q34869890-346C1185-B4DB-475C-8A43-8CA776E24E7A

Q34869890-3F902837-9BA8-41B0-86C7-1A9DACA261C8

Q34869890-80D92D8E-233A-4A01-8AFF-BBA1ECC98CBB

Q34869890-867943A1-0796-4DAB-8741-627E770AF367

Q34869890-D956A1E4-4D0D-4213-AE7B-958A424695EB

P2860

Q34869890-02D73CD7-6196-4EC7-BDEF-A2763A265EE9

Q34869890-12C7AC9D-02FB-491A-B75B-B803B199B482

Q34869890-150AF4FD-9258-4D4C-93C9-B28D5EFB03FF

Q34869890-17335A40-3E36-48C3-87BD-DCF6FE334D6C

Q34869890-256F8AAC-F943-470E-B477-E9C3FA48460E

Q34869890-2A16D150-0EF9-484A-A3BA-5CDD07161508

Q34869890-3D8357BC-7349-455F-976C-BAF330613FCF

Q34869890-41ECEED7-2375-4F21-BC72-EAA6FE5E8586

Q34869890-42642E58-3F16-4629-A579-4AD1F7D40194

Q34869890-46757DFD-F680-4459-8257-7D8BD00418FA

P304

Q34869890-F9242342-74CA-4C5E-952C-D3C354CA0A98

P31

Q34869890-4F4FD58A-2E84-413E-AC48-2DDBA2EBF031

P356

Q34869890-F417102D-D3F6-4B62-961F-B7A9A4F0E32E

P433

Q34869890-810699D9-3FCD-435B-98E6-F35C5B16C3B2

P478

Q34869890-A44197AF-895E-4E37-BCCB-857F67AE477D

P50

Q34869890-97646552-E7CF-4616-A026-222700BD29F8

Q34869890-B5AC0046-044B-4EAC-98A4-0A6FF86703DF

P577

Q34869890-D0593135-CE72-4C2F-9361-BAEFB7FC1680

P5875

Q34869890-474944CB-9F70-4DE4-8194-5206F78945AE

P698

Q34869890-F44B683B-D165-4C8B-A1E5-35BDEA77C6EA

P921

Q34869890-665BDB76-9A64-4FBC-B3A8-BAD4E7A91C8C

P932

Q34869890-C29DE8EC-401D-4392-9D4C-FE33FF001610

P356

J.BIOMATERIALS.2013.07.011

P1433

P1476

In silico design of anti-atherogenic biomaterials.

@en

P2093

Daniel R Lewis

http://www.w3.org/2001/XMLSchema#string

Latrisha K Petersen

http://www.w3.org/2001/XMLSchema#string

Michael D Tomasini

http://www.w3.org/2001/XMLSchema#string

Prabhas V Moghe

http://www.w3.org/2001/XMLSchema#string

Vladyslav Kholodovych

http://www.w3.org/2001/XMLSchema#string

William J Welsh

http://www.w3.org/2001/XMLSchema#string

P2860

GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation

Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture

ACPYPE - AnteChamber PYthon Parser interfacE

Online chemical modeling environment (OCHEM): web platform for data storage, model development and publishing of chemical information

Inflammation and atherosclerosis

The MARTINI force field: coarse grained model for biomolecular simulations

Activation of innate immune responses in a pathogen-mimicking manner by amphiphilic polyanhydride nanoparticle adjuvants.

Development and application of hybrid structure based method for efficient screening of ligands binding to G-protein coupled receptors.

Prediction of Fibrinogen Adsorption for Biodegradable Polymers: Integration of Molecular Dynamics and Surrogate Modeling

Novel trends in high-throughput screening.

P304

7950-7959

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BIOMATERIALS.2013.07.011

http://www.w3.org/2001/XMLSchema#string

P433

32

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

Dalia S Abdelhamid

P577

2013-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

253333694

http://www.w3.org/2001/XMLSchema#string

P698

23891521

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

3880781

http://www.w3.org/2001/XMLSchema#string